hellomed secures €6M to prevent medication errors

Medication errors represent one of the most underestimated risks in professional care. In Germany alone, an estimated 250,000 hospital admissions occur annually due to incorrect medication, resulting in costs of up to €1 billion per year. Behind these figures are not just financial burdens, but preventable risks for patients and additional pressure on nursing staff.

Berlin-based hellomed has secured €6 million in venture capital to scale its digital medication management solution across Germany. The funding round was led by Zurich-based EquityPitcher Ventures, with significant participation from IBB Ventures and zwei.7, according to the company's press release.
 

"Medication management is one of the most sensitive processes in professional care, and unfortunately also one of the most error-prone," says Enrico Bernardo, founder and CEO of hellomed. "When something goes wrong here, it doesn't just affect workflows, but human lives."

The company's platform, hellomedOS, digitizes critical medication workflows between care facilities and specialized partner pharmacies. It integrates into existing care management systems and automates processes that are currently manual and error-prone: unclear medication plans, fragmented communication between nurses, doctors and pharmacies, and incomplete documentation during therapy changes.

"Our solution brings order to an area that today is often characterized by paperwork and follow-up questions," explains Tim Bogdan, hellomed's Managing Director for Care. The software aims to save nursing staff several hours per week per person while systematically eliminating medication errors.

hellomed is already connected to Germany's telematics infrastructure and uses AI-based components to capture, structure and merge medication plans from different sources. The company plans to expand from serving 100 care facilities today to over 2,000 by 2030, targeting a market worth more than €8 billion.

 

Back